Article
Allele-specific p53 mutant reactivation.
Cancer cell - 15 May 2012
Yu Xin, Vazquez Alexei, Levine Arnold J, Carpizo Darren R
Abstract excerpt
Rescuing the function of mutant p53 protein is an attractive cancer therapeutic strategy. Using the National Cancer Institute's anticancer drug screen data, we identified two compounds from the thiosemicarbazone family that manifest increased growth inhibitory activity in mutant p53 cells, particularly for the p53(R175) mutant. Mechanistic studies reveal that NSC319726 restores WT structure and function to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
